Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesTreatment OutcomeKidney TransplantationHematopoiesisRecurrenceTime FactorsCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionGraft RejectionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidFollow-Up StudiesImmunosuppressionLymphocyte DepletionStem Cell TransplantationLymphoma, Non-HodgkinLeukocyte TransfusionAcute DiseaseHeart TransplantationProspective StudiesRetrospective StudiesRisk FactorsSevere Combined ImmunodeficiencySurvival AnalysisChimeraT-LymphocytesColony-Forming Units AssayHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisCyclosporineBone DensityHematologic DiseasesLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyEuropeCarmustineOrgan TransplantationPancytopeniaCell DifferentiationGraft vs Tumor EffectSurvival RateGraft vs Leukemia EffectCytarabineLeukocyte CountCytomegalovirus InfectionsSpleenBone ResorptionGranulocyte Colony-Stimulating FactorMelphalanDisease-Free SurvivalMice, Inbred BALB CEtoposideCase-Control StudiesFlow CytometryLymphomaMultiple MyelomaCells, CulturedIncidenceFatal OutcomePrognosisHodgkin DiseaseAntigens, CD34